PharmiWeb23m
Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study
For immediate release Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study First FcRn blocker to demonstrate sustained ...
PharmiWeb27m
Innovative Trials appoints new Finance and Business Services Director to drive business growth
Innovative Trials appoints new Finance and Business Services Director to drive business growth Innovative Trials, a specialist clinical trial patient engagement, recruitment, and retention company, ...
PharmiWeb31m
Medical Waste Management System Market Expected to Reach USD 15,336.9 Million by 2033 at a 6.6% of CAGR
Medical Waste Management System MarketThe global medical waste management system market is set to be valued at approximately ...
PharmiWeb41m
Next Generation Mass Spectrometer Market Set to Reach USD 4,097.1 Million by 2032 at a 7.2% of CAGR
Next Generation Mass Spectrometer MarketThe global next generation mass spectrometer market achieved a valuation of ...
PharmiWeb41m
Exonucleases Market Projected to Reach USD 208.1 Million by 2032 at a 2.3% of CAGR
Exonucleases MarketThe global exonucleases market, valued at approximately USD 162.6 million in 2022, is on track for steady growth over the next decade. Forecasts indicate a compound annual growth ...
PharmiWeb42m
Global Anti-Adhesion Barrier Gels Market Projected to Reach USD 93.42 Million by 2021, Growing at a Robust CAGR of 8.4%
Global Anti-Adhesion Barrier Gels MarketThe global anti-adhesion barrier gels market is poised for significant growth, with ...
PharmiWeb42m
Insulin Biosimilar Market Projected to Reach USD 5…
Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...
PharmiWeb43m
UCB showcases new data for gMG management at the 2…
UCB will contribute 14 presentations, including an oral presentation, selected to feature across the AANEM and MGFA meeting, emphasizing UCB's leadership in neuromuscular researchPresentations ...
PharmiWeb57m
Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK
Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK ·       Developed with a higher antigen content to increase protection in older adults, a population at greater ...
PharmiWeb59m
Implantable Infusion Pump Market Projected to Reach USD 892.6 Million by 2032 at a 5.7% of CAGR
Implantable Infusion Pump MarketThe global implantable infusion pump market is set to witness significant growth, with an expected valuation of approximately USD 485.1 million in 2022. The market is ...
PharmiWeb59m
Glioblastoma Treatment Drugs Market Set to Reach USD 1,317.4 Million by 2033 at a 5.7% of CAGR
Glioblastoma Treatment Drugs MarketThe glioblastoma treatment drugs market is poised for substantial growth, with a projected valuation of approximately USD 756.1 million in 2023. The market is ...
PharmiWeb1h
Minimally Invasive Neurosurgery Devices Market Expected to Surpass USD 5,950.1 Million by 2033 at a 6.3% of CAGR
Minimally Invasive Neurosurgery Devices MarketThe global minimally invasive neurosurgery devices market is valued at approximately USD 3,227.9 million in 2023, with projections indicating a robust ...